These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 27648082

  • 1. External beam boost versus interstitial high-dose-rate brachytherapy boost in the adjuvant radiotherapy following breast-conserving therapy in early-stage breast cancer: a dosimetric comparison.
    Terheyden MM, Melchert C, Kovács G.
    J Contemp Brachytherapy; 2016 Aug; 8(4):294-300. PubMed ID: 27648082
    [Abstract] [Full Text] [Related]

  • 2. Dosimetric analysis of breast cancer tumor bed boost: An interstitial brachytherapy vs. external beam radiation therapy comparison for deeply seated tumors.
    Shahbazian H, Bakhshali R, Shamsi A, Bagheri A.
    Brachytherapy; 2020 Aug; 19(2):264-274. PubMed ID: 31787575
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
    Oehler-Jänne C, Seifert B, Lütolf UM, Studer G, Glanzmann C, Ciernik IF.
    Brachytherapy; 2007 Aug; 6(3):218-26. PubMed ID: 17681244
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.
    Polgár C, Fodor J, Orosz Z, Major T, Takácsi-Nagy Z, Mangel LC, Sulyok Z, Somogyi A, Kásler M, Németh G.
    Strahlenther Onkol; 2002 Nov; 178(11):615-23. PubMed ID: 12426672
    [Abstract] [Full Text] [Related]

  • 11. A method to estimate composite doses for organs at risk in prostate cancer patients treated with EBRT in combination with HDR BT.
    Pettersson N, Johansson KA, Alsadius D, Tucker SL, Steineck G, Olsson C.
    Acta Oncol; 2014 Jun; 53(6):815-21. PubMed ID: 24460070
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
    Klein J, Ghasem A, Huntley S, Donaldson N, Keisch M, Conway S.
    Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
    Hermesse J, Biver S, Jansen N, Lenaerts E, Nickers P.
    Int J Radiat Oncol Biol Phys; 2010 Jan 01; 76(1):269-76. PubMed ID: 19775833
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multicatheter interstitial brachytherapy versus intensity modulated external beam therapy for accelerated partial breast irradiation: A comparative treatment planning study with respect to dosimetry of organs at risk.
    Major T, Stelczer G, Pesznyák C, Mészáros N, Polgár C.
    Radiother Oncol; 2017 Jan 01; 122(1):17-23. PubMed ID: 27544819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.